Rates, management, and outcome of rivaroxaban bleeding in daily care: results from the Dresden NOAC registry

Worldwide, rivaroxaban is increasingly used for stroke prevention in atrial fibrillation and treatment of venous thromboembolism, but little is known about rivaroxaban-related bleeding complications in daily care. Using data from a prospective, noninterventional oral anticoagulation registry of dail...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Beyer-Westendorf, Jan, Förster, Kati, Pannach, Sven, Ebertz, Franziska, Gelbricht, Vera, Thieme, Christoph, Michalski, Franziska, Köhler, Christina, Werth, Sebastian, Sahin, Kurtulus, Tittl, Luise, Hänsel, Ulrike, Weiss, Norbert
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society of Hematology 2014
Gaiak:
Thrombosis and Hemostasis
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4126334/
https://ncbi.nlm.nih.gov/pubmed/24859362
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2014-03-563577
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak